Estrogen-based therapy is now recommended first for vasomotor symptoms, with SNRIs, SSRIs, gabapentin, and neurokinin receptor antagonists reserved for later lines.
Starting with 30% oxygen did not change ongoing support at delivery-room exit, although exploratory findings suggested less intensive respiratory care.
Review identifies recurring sex-based differences across specialties, including lower use of intensive and guideline-compliant treatment among female patients.